Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JMP Securities Downgrades Intellia Therapeutics to Market Perform

JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.
byBenzinga Newsdesk
January 19, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts